{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:50:23Z","timestamp":1793317823131,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00520-025-09365-1","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T18:17:23Z","timestamp":1742840243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Walking inability in children during early treatment of acute lymphoblastic leukaemia: incidence and risk factors"],"prefix":"10.1007","volume":"33","author":[{"given":"Emma","family":"den Hartog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge M.","family":"van der Sluis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"van der Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim J. E.","family":"Tissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Verwaaijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"issue":"1","key":"9365_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pcl.2014.09.006","volume":"62","author":"SL Cooper","year":"2015","unstructured":"Cooper SL, Brown PA (2015) Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am 62(1):61\u201373. https:\/\/doi.org\/10.1016\/j.pcl.2014.09.006","journal-title":"Pediatr Clin North Am"},{"issue":"16","key":"9365_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373(16):1541\u20131552","journal-title":"N Engl J Med"},{"issue":"6","key":"9365_CR3","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 7(6):e577\u2013e577","journal-title":"Blood Cancer J"},{"issue":"8","key":"9365_CR4","first-page":"A4883","volume":"61","author":"N Brix","year":"2014","unstructured":"Brix N, Rosth\u00f8j S (2014) Bone marrow involvement is not manifest in the early stages of childhood acute lymphoblastic leukaemia. Dan Med J 61(8):A4883","journal-title":"Dan Med J"},{"key":"9365_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-39708-5_2","volume-title":"Childhood Acute Lymphoblastic Leukemia","author":"J Moppett","year":"2017","unstructured":"Moppett J, Dommett R (2017) Clinical presentation and prognostic factors. Childhood Acute Lymphoblastic Leukemia. Cham, Springer International Publishing, pp 29\u201348"},{"key":"9365_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4939-2895-8_7","volume-title":"Glucocorticoid Signaling: From Molecules to Mice to Man","author":"SC Bodine","year":"2015","unstructured":"Bodine SC, Furlow JD (2015) Glucocorticoids and skeletal muscle. Glucocorticoid Signaling: From Molecules to Mice to Man. Springer, New York, pp 145\u2013176"},{"issue":"3","key":"9365_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/00075197-199905000-00002","volume":"2","author":"P-O Hasselgren","year":"1999","unstructured":"Hasselgren P-O (1999) Glucocorticoids and muscle catabolism. Curr Opin Clin Nutr Metab Care 2(3):201\u2013205","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"9365_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","volume":"84","author":"ML Madsen","year":"2019","unstructured":"Madsen ML, Due H, Ejskj\u00e6r N, Jensen P, Madsen J, Dybk\u00e6r K (2019) Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. Cancer Chemother Pharmacol 84:471\u2013485","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"9365_CR9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MPH.0000000000000825","volume":"39","author":"M Kavcic","year":"2017","unstructured":"Kavcic M et al (2017) Electrophysiological studies to detect peripheral neuropathy in children treated with vincristine. J Pediatr Hematol Oncol 39(4):266\u2013271","journal-title":"J Pediatr Hematol Oncol"},{"key":"9365_CR10","unstructured":"Dutch Childhood Oncology Group (2018) PROTOCOL ALL-11 Treatment study protocol of the Dutch Childhood Oncology Group for children and adolescents (1\u201319 year) with newly diagnosed acute lymphoblastic leukemia. ed."},{"key":"9365_CR11","unstructured":"Heyman M (2020) ALLTOGETHER ALLTogether1 \u2013 a treatment study protocol of the ALLTogether Consortium for children and young adults (1\u201345 years of age) with newly diagnosed acute lymphoblastic leukaemia (ALL). ed."},{"issue":"8","key":"9365_CR12","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/leu.2011.84","volume":"25","author":"O Teuffel","year":"2011","unstructured":"Teuffel O et al (2011) Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia 25(8):1232\u20131238","journal-title":"Leukemia"},{"issue":"3","key":"9365_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/pbc.22055","volume":"53","author":"C Winter","year":"2009","unstructured":"Winter C et al (2009) Level of activity in children undergoing cancer treatment. Pediatr Blood Cancer 53(3):438\u2013443. https:\/\/doi.org\/10.1002\/pbc.22055","journal-title":"Pediatr Blood Cancer"},{"key":"9365_CR14","doi-asserted-by":"publisher","first-page":"103004","DOI":"10.1016\/j.critrevonc.2020.103004","volume":"152","author":"A Coombs","year":"2020","unstructured":"Coombs A, Schilperoort H, Sargent B (2020) \u201cThe effect of exercise and motor interventions on physical activity and motor outcomes during and after medical intervention for children and adolescents with acute lymphoblastic leukemia: a systematic review\u201d, (in eng). Crit Rev Oncol Hematol 152:103004. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"9365_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1467-9469.2006.00529.x","volume":"34","author":"HC Van Houwelingen","year":"2007","unstructured":"Van Houwelingen HC (2007) Dynamic prediction by landmarking in event history analysis. Scand J Stat 34(1):70\u201385. https:\/\/doi.org\/10.1111\/j.1467-9469.2006.00529.x","journal-title":"Scand J Stat"},{"key":"9365_CR16","unstructured":"R: a language and environment for statistical computing (2023) R Foundation for Statistical Computing, Vienna, Austria. Available:https:\/\/www.R-project.org[Online]. Accessed 20 Sept 2024"},{"issue":"6","key":"9365_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/(sici)1096-911x(199912)33:6<545::aid-mpo4>3.0.co;2-y","volume":"33","author":"H Reinders-Messelink","year":"1999","unstructured":"Reinders-Messelink H et al (1999) Motor performance of children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 33(6):545\u2013550. https:\/\/doi.org\/10.1002\/(sici)1096-911x(199912)33:6%3c545::aid-mpo4%3e3.0.co;2-y","journal-title":"Med Pediatr Oncol"},{"key":"9365_CR18","doi-asserted-by":"crossref","unstructured":"Hamari L et al (2020) Motor performance in children diagnosed with cancer: a longitudinal observational study. Children 7(8): 98. [Online]. Available: https:\/\/www.mdpi.com\/2227-9067\/7\/8\/98.","DOI":"10.3390\/children7080098"},{"issue":"4","key":"9365_CR19","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3109\/10428194.2014.944519","volume":"56","author":"KK Ness","year":"2015","unstructured":"Ness KK et al (2015) Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia. Leuk Lymphoma 56(4):1004\u20131011","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"9365_CR20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1365-2141.2010.08192.x","volume":"149","author":"JL McNeer","year":"2010","unstructured":"McNeer JL, Nachman JB (2010) The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. Br J Haematol 149(5):638\u2013652. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08192.x","journal-title":"Br J Haematol"},{"issue":"10","key":"9365_CR21","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1182\/blood-2002-08-2454","volume":"101","author":"BC Bostrom","year":"2003","unstructured":"Bostrom BC et al (2003) Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group. Blood 101(10):3809\u20133817. https:\/\/doi.org\/10.1182\/blood-2002-08-2454","journal-title":"Blood"},{"issue":"6","key":"9365_CR22","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1365-2141.2005.05509.x","volume":"129","author":"CD Mitchell","year":"2005","unstructured":"Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TO (2005) Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol 129(6):734\u2013745. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05509.x","journal-title":"Br J Haematol"},{"issue":"10","key":"9365_CR23","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/s2352-4642(18)30236-0","volume":"2","author":"KL Bjornard","year":"2018","unstructured":"Bjornard KL et al (2018) Peripheral neuropathy in children and adolescents treated for cancer. Lancet Child Adolesc Health 2(10):744\u2013754. https:\/\/doi.org\/10.1016\/s2352-4642(18)30236-0","journal-title":"Lancet Child Adolesc Health"},{"issue":"8","key":"9365_CR24","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/jnci\/djac095","volume":"114","author":"RL Rodwin","year":"2022","unstructured":"Rodwin RL et al (2022) Persistence of chemotherapy-induced peripheral neuropathy despite vincristine reduction in childhood B-acute lymphoblastic leukemia. J Natl Cancer Inst 114(8):1167\u20131175. https:\/\/doi.org\/10.1093\/jnci\/djac095","journal-title":"J Natl Cancer Inst"},{"key":"9365_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF02072486","volume":"152","author":"L Vainionp\u00e4\u00e4","year":"1993","unstructured":"Vainionp\u00e4\u00e4 L (1993) Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment. Eur J Pediatr 152:115\u2013119","journal-title":"Eur J Pediatr"},{"issue":"7","key":"9365_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1080\/08880018.2022.2045409","volume":"39","author":"JM Brito-Su\u00e1rez","year":"2022","unstructured":"Brito-Su\u00e1rez JM, Camacho-Ju\u00e1rez F, S\u00e1nchez-Medina CM, Hern\u00e1ndez-Pliego G, Guti\u00e9rrez-Camacho C (2022) Gross motor disorders in pediatric patients with acute lymphoblastic leukemia and survivors: a systematic review. Pediatr Hematol Oncol 39(7):658\u2013671. https:\/\/doi.org\/10.1080\/08880018.2022.2045409","journal-title":"Pediatr Hematol Oncol"},{"issue":"6","key":"9365_CR27","first-page":"493","volume":"17","author":"A Cruz Martinez","year":"1977","unstructured":"Cruz Martinez A, Perez Conde MC, Ferrer MT (1977) Motor conduction velocity and H-reflex in infancy and childhood: study in newborns, twins and small-for-dates. Electromyogr Clin Neurophysiol 17(6):493\u2013505","journal-title":"Electromyogr Clin Neurophysiol"},{"issue":"1","key":"9365_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/pbc.21942","volume":"53","author":"A Hartman","year":"2009","unstructured":"Hartman A et al (2009) A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 53(1):64\u201371. https:\/\/doi.org\/10.1002\/pbc.21942","journal-title":"Pediatr Blood Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09365-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09365-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09365-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:10:37Z","timestamp":1745305837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09365-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9365"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09365-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Medical Ethical Committee (MEC-2016\u2013739) and the Clinical Research Committee (CRC) of the Princess M\u00e1xima Centre for Pediatric Oncology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants or legal guardians included in the study. Patients signed informed consent regarding publishing their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}